NCT02870933View on ClinicalTrials.gov

Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2019

Conditions
Coronary Artery Disease
Interventions
BIOLOGICAL

Transepicardial with Transseptal CD 133+ Implantation

Transepicardial with Transseptal CD 133+ Implantation

Trial Locations (1)

11420

National Cardiovascular Center Harapan Kita, Jakarta

All Listed Sponsors
lead

National Cardiovascular Center Harapan Kita Hospital Indonesia

OTHER

NCT02870933 - Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery | Biotech Hunter | Biotech Hunter